The Huntsman Cancer Institute External Advisory Board (EAB) serves in a consultative capacity and is charged to provide planning and oversight guidance for HCI to strengthen our cancer research programs. The EAB evaluates the scientific merit of HCI's cancer research programs and their standing in the national and international scientific communities as well as the quality of clinical and translational programs and the overall direction of HCI.

	Edward Benz, MD President, Dana-Farber Cancer Institute Richard and Susan Smith Professor of Medicine, Professor of Pediatrics, Professor of Pathology Harvard Medical School
	Elizabeth H. Blackburn, PhD Nobel Laureate Professor, Morris Herzstein Biochemistry and Biophysics Department University of California, San Francisco
	Michael Caligiuri, MD Director, Comprehensive Cancer Center CEO, James Cancer Hospital & Solove Research Institute JL Marakas Nationwide Insurance Enterprise Foundation Professor of Cancer Research The Ohio State University
	Robert DuWors, MPA Deputy Director, Administration and Finance Jonsson Comprehensive Cancer Center University of California at Los Angeles
	Elaine Fuchs, PhD Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development Howard Hughes Medical Institute Investigator The Rockefeller University
	Ernest T. Hawk, MD, MPH Vice President, Cancer Prevention and Population Sciences The University of Texas, M. D. Anderson Cancer Center
	Timothy R. Rebbeck, PhD Professor of Epidemiology Director of the Center for Genetics and Complex Traits, Director of the Laboratory for Molecular Epidemiology Associate Director for Population Science in the Abramson Cancer Center University of Pennsylvania
	Max S. Wicha, MD Distinguished Professor of Oncology Professor of Internal Medicine Director, Comprehensive Cancer Center University of Michigan

Past Members

Alfred G. Gilman, MD, PhD, Nobel Laureate
Raymond and Ellen Willie Distinguished
Chair in Molecular Neuropharmacology
Distinguished Chair in Molecular
Neuropharmacy
in honor of Harold B. Crasilneck, PhD
Regental Professor

Executive Vice President of
Academic Affairs and Provost Dean
Professor and Chairman
Department of Pharmacology
University of Texas Southwestern Medical Center at Dallas

Bernadine Healy, MD
Member, Presidents Council of
Advisors on Science and Technology

Former Director
National Institutes of Health

Former President and CEO
American Red Cross

Stanley J. Korsmeyer, MD
Sidney Farber Professor of Pathology and Professor of Medicine
Harvard Medical School

Investigator, Howard Hughes Medical Institute

Director, Program in Molecular Oncology
Dana-Faber Cancer Institute

Bernard Levin, MD
Professor, Gastrointestinal Medicine
and Nutrition

Vice President, Cancer Prevention and
Population Sciences
University of Texas
MD Anderson Cancer Center

Arnold J. Levine, MD
Former President, Rockefeller University

Professor, Simons Center for Systems
Biology, Institute for Advanced Study

Professor, Pediatrics and Biochemistry
Cancer Institute of New Jersey

Rae Ann Paden
Associate Director, Research Administration
University of New Mexico Cancer Center
Albuquerque, New Mexico

Saul A. Rosenberg, MD
Maureen Lyles D'Ambrogio
Professor of Medicine and Radiation Oncology, Emeritus
Stanford University School of Medicine
Stanford, California

Richard L. Schilsky, MD
Professor of Medicine, Chairman, Cancer and Leukemia Group B
Biological Sciences Division
University of Chicago

Phillip A. Sharp, PhD, Nobel Laureate
Salvadore E. Luria Professor of Biology

Director, McGovern Institute for Brain Research
Massachusetts Institute of Technology

Ajit Varki, MD
Distinguished Professor of Medicine
Director, Glycobiology Research and Training Center

Former Director
University of California, San Diego
Cancer Center

Robert C. Young, MD
Chancellor, Fox Chase Cancer Center
Philadelphia, Pennsylvania